Skip to main content
Valeo Pharma Inc. (VPHIF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Feb 11, 2026

Valeo Pharma Revenue

Valeo Pharma had revenue of 12.60M CAD in the quarter ending July 31, 2024, a decrease of -10.52%. This brings the company's revenue in the last twelve months to 53.38M, down -0.16% year-over-year. In the fiscal year ending October 31, 2023, Valeo Pharma had annual revenue of 53.91M with 94.31% growth.

Revenue (ttm)
53.38M CAD
Revenue Growth
-0.16%
P/S Ratio
n/a
Revenue / Employee
762.53K CAD
Employees
70
Market Cap
99.00 USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Oct 31, 202353.91M26.17M94.31%
Oct 31, 202227.75M14.19M104.65%
Oct 31, 202113.56M6.09M81.49%
Oct 31, 20207.47M893.00K13.58%
Oct 31, 20196.58M2.20M50.09%
Oct 31, 2018 Pro Pro Pro
Oct 31, 2017 Pro Pro Pro
Oct 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MJardin Group 4.81M
Chalice Brands 25.96M
Allied 104.81K
Isodiol International 12.18M
SES Solar 5.51M
TransCanna Holdings 2.97M
Revenue Rankings

Valeo Pharma News

More News